Ipsilateral breast tumour recurrence in hereditary breast cancer following breast-conserving therapy

Autor: Caroline Seynaeve, E.J. Meijers-Heijboer, Anja Wagner, Carien L. Creutzberg, Martinus F. Niermeijer, C.T.M. Brekelmans, A.N. van Geel, A. M. W. Van Den Ouweland, L.M.C van de Bosch, L.C. Verhoog, J.G.M. Klijn, Marian B. E. Menke-Pluymers

Publikováno v: European Journal of Cancer, 40, 1150-1158. Elsevier Ltd.
European journal of cancer (Oxford, England, 40(8), 1150-1158. Elsevier Limited
European Journal of Cancer, 40, 8, pp. 1150-8
European Journal of Cancer, 40, 1150-8

Contains fulltext : 57795.pdf (Publisher’s version ) (Closed access) The overall rate of an ipsilateral breast tumour recurrence (IBTR) after breast-conserving therapy (BCT) ranges from 1% to 2% per year. Risk factors include young age but data on

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21ffa7eaa145d62a3f2013f007eaa2f9
https://doi.org/10.1016/j.ejca.2004.01.017